Impact of age, sex and medical history on adverse reactions to the first and second dose of BNT162b2 mRNA COVID-19 vaccine in Japan: a cross-sectional study

Peer Review reports

Original Submission
18 Nov 2021	Submitted	Original manuscript
13 Dec 2021	Reviewed	Reviewer Report
22 Dec 2021	Reviewed	Reviewer Report
20 Jan 2022	Author responded	Author comments - Ryuta Urakawa
Resubmission - Version 2
20 Jan 2022	Submitted	Manuscript version 2
Publishing
17 Feb 2022	Editorially accepted
23 Feb 2022	Article published	10.1186/s12879-022-07175-y

Back to article page